DRIVING DRUG DISCOVERY THROUGH STRUCTURE

Biodesy discovers novel therapeutic molecules for difficult-to-drug targets by leveraging its proprietary, structure-driven platform. By combining knowledge about a drug target’s native biology with our novel technology for directly measuring structural changes, we can efficiently identify molecules that induce functionally relevant structural changes in difficult-to-drug targets.